Skip to main content
Article thumbnail
Location of Repository

Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean

By Victor R Grann, Elad Ziv, Cecil K Joseph, Alfred I Neugut, Ying Wei, Judith S Jacobson, Marshall S Horwitz, Natalie Bowman, Kenneth Beckmann and Dawn L Hershman


Neutropenia associated with race/ethnicity has essentially been unexplained and, although thought to be benign, may affect therapy for cancer or other illnesses. A recent study linked a single nucleotide polymorphism (SNP) (rs2814778) in the Duffy antigen/receptor chemokine gene (DARC) with white blood cell count. We therefore analysed the association of the rs2814778 CC, TC and TT genotypes with absolute neutrophil count (ANC) among asymptomatic women from the Caribbean, Europe and the United States. Among 261 study participants, 33/47 women from Barbados/Trinidad-Tobago, 34/49 from Haiti, 26/37 from Jamaica, and 29/38 US-born black women, but only 4/50 from the Dominican Republic and 0/40 US- or European-born whites (P = 0·0001) had the CC genotype. In a linear regression model that included percentage African ancestry, national origin, cytokines, socio-economic factors and the ELA2 rs57834246 SNP, only the DARC rs2814778 genotype and C-reactive protein were associated with ANC (P < 0·0001). Women with the CC genotype had lower ANC than other women. Further research is needed on the associations of rs2814778 genotype with neutropenia and treatment delay in the setting of cancer. A better understanding of these associations may help to improve cancer outcomes among individuals of African ancestry

Topics: Haemopoiesis and Leucocytes
Publisher: Blackwell Publishing Ltd
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2003). A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lym-
  2. (1999). Benign ethnic neutropenia: what is a normal absolute neutrophil count?
  3. (1996). Ethnic and sex differences in the total and differential white cell count and platelet count.
  4. (2003). Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer.
  5. (2000). Investigation of the effect of marathon running on leucocyte counts of subjects of different ethnic origins: relevance to the aetiology of ethnic neutropenia.
  6. (2008). National Institutes of Health Consensus Development Conference Statement: hydroxyurea treatment for sickle cell disease.
  7. (2008). Neutropenia in six ethnic groups from the Caribbean and the United States (in press).
  8. (2007). Neutrophil elastase in cyclic and severe congenital neutropenia.
  9. (2007). Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.